Serotonin News and Research

Latest Serotonin News and Research

Human placenta plays an active role in serotonin synthesis

Research at the Keck School of Medicine of the University of Southern California's Zilkha Neurogenetic Institute shows for the first time that the human placenta plays an active role in synthesizing serotonin, paving the way to new treatment strategies that could mitigate health impacts such as cardiovascular disease and mental illness.

22 Apr 2011

Study underscores need for more targeted antidepressant therapies to decrease depressive symptoms

Even people who show a clear treatment response with antidepressant medications continue to experience symptoms like insomnia, sadness and decreased concentration, researchers at UT Southwestern Medical Center have found after analyzing data from the largest study on the treatment of depression.

21 Apr 2011

America’s best loved drugs: Report

According to the latest report from consulting firm IMS Health, Americans are consuming a lot of prescription drugs. And they seem especially fond of those to lower their cholesterol, relieve heartburn, aid in depressive disorders and lessen pain. Overall, however, their spending on such drugs is slowing.

20 Apr 2011

Forest Labs fourth quarter net sales increase 9.7% to $1,091.9 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.12 in the fourth quarter of fiscal 2011.

19 Apr 2011

Serotonin can help promote human intimacy and romantic feelings

The judgments we make about the intimacy of other couples' relationships appear to be influenced by the brain chemical serotonin, reports a new study published in Biological Psychiatry.

15 Apr 2011

Teva presents new CNS products study data in RRMS, Parkinson's at AAN meeting

Teva Pharmaceutical Industries Ltd. today announced that several new studies further support the efficacy and safety of the company's innovative central nervous system products.

12 Apr 2011

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

6 Apr 2011

Study: Antidepressants can thicken arteries and lead to heart disease

Antidepressant use has been linked to thicker arteries, possibly contributing to the risk of heart disease and stroke, in a study of twin veterans. The data is being presented Tuesday, April 5 at the American College of Cardiology meeting in New Orleans.

4 Apr 2011

Antidepressants may increase heart attack or stroke risk in men: Study

...

3 Apr 2011

Early recognition and treatment can control obsessive-compulsive manifestation

Obsessive-compulsive disorder is often diagnosed too late in children and adolescents. In the current issue of Deutsches Ärzteblatt International, Susanne Walitza and her colleagues point out that appropriate early recognition and treatment can positively affect the course of the disease.

1 Apr 2011

Panax ginseng, saffron and yohimbine can boost human sexual function

Looking to spice up your sex life? Try adding ginseng and saffron to your diet. Both are proven performance boosters, according to a new scientific review of natural aphrodisiacs conducted by University of Guelph researchers.

28 Mar 2011

Serotonin influences sexual preference: Study

Researchers from Beijing's National Institute of Biological Sciences, China have found a chemical in the brain controls sexual preference in mice. The study published in the journal Nature said that male mice bred without serotonin lose their preference for females. This is the first study that shows that a neurotransmitter plays a role in sexual preference in mammals. However it is still a long way before similar conclusions can be drawn for humans the experts believe.

24 Mar 2011

Rexahn completes 33% of 300 patient enrollment in Serdaxin Phase IIb clinical trial for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).

24 Mar 2011

Researchers discover a type of 'cellular bilingualism' in brain

A team of researchers from the University of Montreal and McGill University have discovered a type of "cellular bilingualism" - a phenomenon that allows a single neuron to use two different methods of communication to exchange information.

18 Mar 2011

Study investigates physiological changes within brain due to Prozac treatment

Selective serotonin reuptake inhibitors (SSRI) such as Prozac are regularly used to treat severe anxiety and depression. They work by immediately increasing the amount of serotonin in the brain and by causing long term changes in brain function. However it can take weeks of treatment before a patient feels any effect and both beneficial effects and side effects can persist after treatment is stopped.

16 Mar 2011

Euthymics Bioscience initiates EB-1010 phase 2b/3a TRIADE clinical trial for major depressive disorder

Euthymics Bioscience, Inc. today announced the initiation of an advanced clinical study of its lead product candidate EB-1010 for the treatment of major depressive disorder (MDD). The TRIADE (Triple Reuptake Inhibitor Anti-Depressant Effects) trial is a phase 2b/3a clinical trial designed to assess the safety and efficacy of EB-1010, a novel serotonin-preferring triple reuptake inhibitor.

14 Mar 2011

Transcept initiates enrollment in TO-2061 Phase 2 study for treatment resistant obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.

14 Mar 2011

Prolonged exposure to antidepressants can induce tardive dysphoria

In the current issue of Psychotherapy and Psychosomatics a new important side effect of antidepressant drugs is described: tardive dysphoria.

9 Mar 2011

UH conducts first ever pilot study to test heat therapy for treatment of PE

University Hospitals Case Medical Center is conducting the first ever pilot study to test a new procedure using "heat therapy" or local radiofrequency energy to treat premature ejaculation.

9 Mar 2011

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Thanks in part to a Norwegian research biobank, researchers have generated important new insight into ADHD and how the condition manifests itself. Among other things, they have found that there is some overlap between ADHD and bipolar disorders with regard to rapid mood swings.

2 Mar 2011

Serotonin News and Research

Latest Serotonin News and Research

Human placenta plays an active role in serotonin synthesis

Study underscores need for more targeted antidepressant therapies to decrease depressive symptoms

America’s best loved drugs: Report

Forest Labs fourth quarter net sales increase 9.7% to $1,091.9 million

Serotonin can help promote human intimacy and romantic feelings

Teva presents new CNS products study data in RRMS, Parkinson's at AAN meeting

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Study: Antidepressants can thicken arteries and lead to heart disease

Antidepressants may increase heart attack or stroke risk in men: Study

Early recognition and treatment can control obsessive-compulsive manifestation

Panax ginseng, saffron and yohimbine can boost human sexual function

Serotonin influences sexual preference: Study

Rexahn completes 33% of 300 patient enrollment in Serdaxin Phase IIb clinical trial for major depressive disorder

Researchers discover a type of 'cellular bilingualism' in brain

Study investigates physiological changes within brain due to Prozac treatment

Euthymics Bioscience initiates EB-1010 phase 2b/3a TRIADE clinical trial for major depressive disorder

Transcept initiates enrollment in TO-2061 Phase 2 study for treatment resistant obsessive compulsive disorder

Prolonged exposure to antidepressants can induce tardive dysphoria

UH conducts first ever pilot study to test heat therapy for treatment of PE

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Serotonin News and Research

Latest Serotonin News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in